RTI Surgical entered into an agreement with Oxford Performance Materials (OPM), gaining exclusive license for use of OsteoFab® additive manufacturing technology for spinal applications across the U.S.
The OsteoFab manufacturing process builds implantable medical devices layer by layer, using laser light and OPM’s OXPEKK® polymer.
Under the agreement, OPM will manufacture RTI’s spinal implants using OsteoFab technology; RTI will oversee finishing, packaging, marketing and distribution of finished products.
Source: RTI Surgical, Inc.
A special closing session devoted wholly to additive manufacturing will cap OMTEC 2016, dedicating undivided time to the manufacturing process.
Led by Andy Christensen, who has been active in the additive manufacturing industry since 1996, this session will convene OEM and supplier experts as they forecast additive manufacturing advancements and adoption in orthopaedics over the next five years. The panel will discuss opportunities and challenges surrounding materials, applications, mass production and government regulations. They will call on their experience with the technology to share solutions for successful implementation by others.
OMTEC registration is open now. Visit OMTECexpo.com to see all education and partnership opportunities available.